Cosentyx (secukinumab) is a prescription drug that’s used to treat conditions such as plaque psoriasis and psoriatic arthritis. Cosentyx is given as an injection under the skin or as an IV infusion.
Novartis announced today that the European Commission (EC) has approved Cosentyx ® (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results